|
|
|
| Press Releases |
| LabVantage in the News 2007 |
|
|
|
| Multiple Myeloma Research Consortium Shares its Insights into Effective and Efficient Biospecimen Management |
 |
Bridgewater, NJ. May 28, 2007. LabVantage today announced a new webcast featuring the Multiple Myeloma Research Consortium (MMRC). The MMRC shares its insights into the implementation of LabVantage’s Sapphire BioBanking Solution for the effective and efficient biospecimen management system to support myeloma research throughout MMRC's partner network.
In the cutting-edge world of research, accurate, compliant and efficient management of biospecimens is critical. These specimens serve as the basis for novel research and development of tomorrow's drugs and medical treatments. The MMRC reviews the unique challenges of sample collection, storage, management, and reporting associated with its myeloma specimens. It also addresses the specific barriers to specimen management and data warehousing faced by the MMRC, including how to: span the life cycle of the specimen, address the needs of multiple end users, capture correlating clinical data, maintain flexibility, and provide global visibility.
This webcast and further information about LabVantage's Sapphire BioBanking Solution are available at http://www.labvantage.com/products/biobanking/index.html.
About the MMRC Tissue Bank. The MMRC Tissue Bank is the only resource of its kind that provides researchers with the critical mass of high-quality myeloma tissue samples and related biospecimens necessary to rapidly advance research and drug discovery efforts. Notably, all tissue accrued into the MMRC Tissue Bank is uniformly collected and stored in adherence with Good Laboratory Practices (GLP) standards and under the governance of more than 50 standard operating procedures. With more than 400 patient tissue samples accrued to date and ongoing accrual at sites nationwide, researchers for the first time have access to the critical mass of tissue necessary to support important genomic studies, robust pre-clinical validation efforts, and critical correlative analyses.
About the Multiple Myeloma Research Consortium (MMRC). The Multiple Myeloma Research Consortium (MMRC) is a 509a3 non-profit organization that integrates leading academic institutions to accelerate drug development in multiple myeloma. It is comprised of the MMRC and 10 member institutions: Dana-Farber Cancer Institute, Emory University’s Winship Cancer Institute, Hackensack University Medical Center, H. Lee Moffitt Cancer Center & Research Institute, Mayo Clinic, Ohio State University, Roswell Park Cancer Institute, St. Vincent’s Comprehensive Cancer Center of Saint Vincent Catholic Medical Centers of New York, University Health Network (Princess Margaret Hospital), and University of Chicago. The MMRC was founded in 2004 by Kathy Giusti, a myeloma patient, and with the help of the scientific community, as an optimal research model to rapidly address critical challenges in accelerating drug development and explore opportunities in the most promising areas of myeloma research—genomics, compound validation, and clinical trials. The MMRC is the only consortium to join academic institutions through membership agreements, customized IT systems, and an integrated tissue bank. For more information, please visit http://www.themmrc.org.
About LabVantage Solutions, Inc. LabVantage Solutions, Inc., an innovative global provider of enterprise solutions tailored for leading laboratories, serves discovery, development, formulation, process research, raw material testing, and quality management laboratories across multiple industries. LabVantage’s Sapphire, a zero-footprint laboratory information management suite, is tailored to manage an organization's critical laboratory information across its worldwide R&D pipeline and manufacturing supply chain to optimize productivity and more effectively share knowledge. A Chatterjee Management Group company, LabVantage is headquartered in Bridgewater, NJ, U.S.A., with direct or partner coverage in Austria, Belgium, Canada, China, Denmark, Estonia, Finland, France, Germany, Hong Kong, India, Jordan, Latvia, Lithuania, Malaysia, Netherlands, Norway, Oman, Qatar, Saudi Arabia, Singapore, South Africa, Sweden, Switzerland, Taiwan, Thailand, United Arab Emirates, and United Kingdom. Further information about LabVantage and LabVantage Sapphire is available at www.labvantage.com.
LabVantage, Sapphire and their respective logos are trademarks or registered trademarks of LabVantage Solutions, Inc. in the U.S and other countries around the world. |
|
|
|
|
|
